Thymic stromal lymphopoietin: its role and potential as a therapeutic target in asthma

GM Gauvreau, R Sehmi, CS Ambrose… - Expert opinion on …, 2020 - Taylor & Francis
Introduction Thymic stromal lymphopoietin (TSLP), an epithelial cytokine (alarmin), is a
central regulator of the immune response to inhaled environmental insults such as …

Basophils and allergic inflammation

MC Siracusa, BS Kim, JM Spergel, D Artis - Journal of Allergy and Clinical …, 2013 - Elsevier
Basophils were discovered by Paul Ehrlich in 1879 and represent the least abundant
granulocyte population in mammals. The relative rarity of basophils and their phenotypic …

Effect of tezepelumab on airway inflammatory cells, remodelling, and hyperresponsiveness in patients with moderate-to-severe uncontrolled asthma (CASCADE): a …

S Diver, L Khalfaoui, C Emson, SE Wenzel… - The Lancet …, 2021 - thelancet.com
Background Tezepelumab is a human monoclonal antibody that blocks the activity of thymic
stromal lymphopoietin (TSLP), an epithelial cell-derived cytokine. In phase 2b and 3 studies …

Targeting the interleukin pathway in the treatment of asthma

KF Chung - The Lancet, 2015 - thelancet.com
Asthma is a common heterogeneous disease with a complex pathophysiology. Current
therapies based on inhaled corticosteroids and longacting β 2 agonists are effective in …

Epithelial cytokines and pulmonary allergic inflammation

CM Lloyd, S Saglani - Current opinion in immunology, 2015 - Elsevier
Highlights•The triad of cytokines, IL-25, IL-33 and TSLP, play a defined role in allergic
inflammation at mucosal surfaces.•The precise function of these cytokines during human …

Autophagy plays a role in FSTL1-induced epithelial mesenchymal transition and airway remodeling in asthma

T Liu, Y Liu, M Miller, L Cao, J Zhao… - … of Physiology-Lung …, 2017 - journals.physiology.org
Asthma is a chronic disease related to airway hyperresponsiveness and airway remodeling.
Airway remodeling is the important reason of refractory asthma and is associated with …

Unmet need in severe, uncontrolled asthma: can anti-TSLP therapy with tezepelumab provide a valuable new treatment option?

A Menzies-Gow, ME Wechsler, CE Brightling - Respiratory research, 2020 - Springer
Despite treatment with standard-of-care medications, including currently available biologic
therapies, many patients with severe asthma have uncontrolled disease, which is associated …

Immune induction of airway remodeling

G Guida, AM Riccio - Seminars in immunology, 2019 - Elsevier
Airway remodeling is accepted to be a determining component within the natural history of
asthma. It is a phenomenon characterized by changes in the airways structures that marches …

Tezepelumab in patients with allergic and eosinophilic asthma

M Caminati, R Buhl, J Corren, NA Hanania, H Kim… - Allergy, 2024 - Wiley Online Library
Asthma is a heterogeneous disease commonly driven by allergic and/or eosinophilic
inflammation, both of which may be present in severe disease. Most approved biologics for …

Potential role of cellular senescence in asthma

ZN Wang, RN Su, BY Yang, KX Yang… - Frontiers in cell and …, 2020 - frontiersin.org
Cellular senescence is a complicated process featured by irreversible cell cycle arrest and
senescence-associated secreted phenotype (SASP), resulting in accumulation of senescent …